Scientific Advisory Board

Philip Calder, Ph.D.

Philip Calder, Ph.D. of South Hampton University in Hampton, United Kingdom, has over 25 years of experience in biochemistry and researching dietary fatty acids. His therapeutic area of focus on our Scientific Advisory Board is Non-Alcoholic Fatty Liver Disease (NAFLD). Dr. Calder is currently a Professor in Nutritional Immunology at the University of Southampton. He was appointed to a personal Chair in Nutritional Immunology in 2002. Dr. Calder’s research focuses on understanding the influence of dietary fatty acids on aspects on cell function and human health, in particular, relation to Cardiovascular Disease, inflammation and immunity.

Publications

Steven Freedman, M.D., Ph.D.

Steven Freedman M.D., Ph.D. is the Chief of the Division of Translational Research and Professor of Medicine at Harvard Medical School. Dr. Freedman is the Director of The Pancreas Center and a worldwide leading expert on pancreatic disease and Cystic Fibrosis. His laboratory is translationally based with strong basic science and clinical research components. Dr. Freedman’s expertise is in Exocrine Pancreatic Insufficiency (EPI) with a particular focus on Pancreatitis and Cystic Fibrosis in both adults and children. He is an internationally recognized leader in these areas with an extensive research program that encompasses both basic science as well as clinical trials of new therapies for Pancreatitis and Cystic Fibrosis. In addition, his group has identified an association between Cystic Fibrosis gene mutations and the development of Chronic Pancreatitis and Primary Sclerosing Cholangitis (PSC).

Kathleen Gura, Pharm.D., BCNSP, FASHP, FPPAG

Kathleen Gura, Pharm.D., BCNSP, FASHP, FPPAG of Harvard/Boston Children’s Hospital in Boston, Massachusetts, is a Clinical Pharmacist GI/Nutrition Team Leader, Surgical Programs at the Boston Children’s Hospital. Dr. Gura’s therapeutic focus on our Scientific Advisory Board is Pediatrics.

Matthew Heeney, M.D.

Matthew Heeney, M.D. is a Director, Clinical Hematology; Director, Sickle Cell Program, and Assistant Professor of Pediatrics, Harvard Medical School. Dr Heeney received his M.D. at the University of Calgary, Alberta. His residency was completed at Montreal Children’s Hospital, McGill University and a pediatric hematology/oncology fellowship at Duke University. Dr. Heeney’s research interests are sickle cell disorders and treatment, iron homeostasis in humans, and genetic basis of iron resistant iron deficiency.

Ian Lanza, Ph.D.

Ian Lanza, Ph.D. of The Mayo Clinic in Rochester, Minnesota, has over six years of experience in Endocrinology. Dr. Lanza’s therapeutic focus on our Scientific Advisory Board is diabetes and he received his Ph.D. from the University of Massachusetts. His research is focused on discovering effective, realistic and economical approaches to prevent and treat metabolic disorders in the context of obesity, aging and physical inactivity.
Publications

Camilia Martin, M.S., M.D.

Camilia Martin, M.S., M.D. is a Neonatologist at Beth Israel Deaconess Medical Center in Boston, Massachusetts since 1999, and is the Associate Director of the Neonatal Intensive Care Unit (NICU) within the Division of Translational Research. Dr. Martin is also a Harvard Medical School Professor in Pediatrics and studies the impact of nutrition on the development of innate immunity in premature infants and its effect on acute short-term morbidities and long-term outcomes.

Mark Puder, M.D., Ph.D.

Mark Puder M.D., Ph.D. of Harvard/Boston Children’s Hospital in Boston, Massachusetts has over 25 years of experience in medicine and surgery. Dr. Puder’s therapeutic area of focus on our Scientific Advisory Board is Short Bowel Syndrom (SBS) and pediatrics. He obtained his Doctor of Medicine and Doctor of Philosophy degrees from Harvard University, and is currently a Professor of Surgery at Harvard Medical School and Associate in Surgery at Boston Children’s Hospital. Dr. Puder’s research includes SBS, neonatal surgery, and the prevention and treatment of parenteral and enteral nutrition induced liver injury.

Roy Smith, Ph.D.

Roy Smith, Ph.D. of Scripps Research Institute in Jupiter, Florida has over 40 years of experience in biochemistry. Dr. Smith’s therapeutic area of focus on our Scientific Advisory Board is endocrine hormones. Dr. Smith received his Ph.D. in Organic Chemistry from the University of London. He is currently a Professor at the Department of Metabolism and Aging at Scripps Research Institute in Jupiter, Florida; and is focused on understanding the basis of metabolic diseases and identifying the physiological changes that cause loss of function during aging.

Selected References

Herbert Weissbach, Ph.D.

Herbert Weissbach, Ph.D. of Florida Atlantic University in Jupiter, Florida has over 40 years of experience in biochemical research. His therapeutic area of focus on our scientific advisory board is biochemistry. Dr. Weissbach obtained his Ph.D. in biochemistry from The George Washington University, and is currently a Professor at Florida Atlantic University in Jupiter, Florida and he heads the Center for Molecular Biology and Biotechnology. Dr. Weissbach’s key research includes how cells protect against oxidative damage and the role of oxidative damage in age-related diseases and aging.

Recent Publications

img_support1
Sancilio & Company, Inc. 

Google+   Likedin